OBI Pharma, Inc. (TPEX:4174)
Taiwan · Delayed Price · Currency is TWD 31.95
+0.75 (2.40%)
Aug 15, 2025, 2:31 PM CST
OBI Pharma Market Cap
OBI Pharma has a market cap or net worth of 8.40 billion as of August 15, 2025. Its market cap has decreased by -43.53% in one year.
Market Cap
8.40B
Enterprise Value
7.90B
Revenue
61.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
31.95
Market Cap Chart
Since December 12, 2012, OBI Pharma's market cap has decreased from 16.87B to 8.40B, a decrease of -50.19%. That is a compound annual growth rate of -5.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 8.40B | -45.40% |
| Dec 31, 2024 | 15.39B | -3.28% |
| Dec 29, 2023 | 15.91B | 0.50% |
| Dec 30, 2022 | 15.83B | -30.20% |
| Dec 30, 2021 | 22.68B | -13.48% |
| Dec 31, 2020 | 26.21B | 5.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 224.90B |
| PharmaEssentia | 167.97B |
| Bora Pharmaceuticals Co., LTD. | 97.17B |
| Lotus Pharmaceutical | 52.73B |
| Oneness Biotech | 34.00B |
| Lumosa Therapeutics | 28.78B |
| Polaris Group | 27.23B |
| Center Laboratories | 26.78B |